Shousong Cao is an accomplished inventor based in East Amherst, NY (US). He has made significant contributions to the field of pharmaceutical preparations, particularly in cancer therapy. With a total of 3 patents, his work focuses on developing formulations that address critical medical challenges.

Latest Patents

Cao's latest patents include innovative formulations of water-insoluble chemical compounds and methods of using a formulation of compound FL118 for cancer therapy. These patents provide compositions and methods for creating pharmaceutical preparations aimed at treating diseases such as cancer. The compositions feature effective concentrations of a chemical compound, including 10H-1,3-Dioxolo[4,5-g]pyrano[3',4′:6,7]indolizino[1,2-b]quinoline-8,11(7H,12H)-dione, 7-ethyl-7-hydroxy-, (S)-. Additionally, he has developed methodologies for preparing pharmaceutical preparations that can be administered intravenously or orally, particularly for drug compounds that are difficult to dissolve in water.

Another notable patent by Cao is a method for reducing alopecia and bladder toxicity associated with the anti-cancer agent cyclophosphamide. This method involves administering cyclophosphamide alongside a selenium compound to individuals in need of treatment. The selenium compounds can be given before, during, or after the administration of the anti-cancer agent, providing a comprehensive approach to mitigating side effects.

Career Highlights

Cao is currently associated with Health Research, Inc., where he continues to innovate in the field of cancer treatment. His work has garnered attention for its potential to improve patient outcomes and enhance the efficacy of existing therapies.

Collaborations

Throughout his career, Shousong Cao has collaborated with notable colleagues, including Farukh Durrani and Youcef M Rustum. These partnerships have contributed to the advancement of his research and the development of his patented inventions.

Conclusion

Shousong Cao's contributions to cancer therapy through his innovative patents highlight his dedication to improving medical treatments. His work not only addresses significant challenges in the pharmaceutical field but also showcases the potential for future advancements in cancer care.